
Share on:
Carlyle Group has hired investment bank Natixis to explore a sale of its stake in French medical equipment company Groupe Marle.
Marle specializes in orthopaedic implants, made from both alloys and polyethylene, and sells its products worldwide. The company is reported to produce one million implants annually and recorded €85MM (~US $97MM) in revenue for 2015.
Carlyle Group bought an 80% interest in Marle in 2009. The Marle family and management team retained a 20% stake.
Source: Wall Street Journal Â
In October 2015, Marle announced the acquisition of Finortho SAS, a company that specializes in polishing and sintering for rapid prototyping. Finortho was officially incorporated into Marle in January 2016 and became Marle Finishing SAS.
RELATED ARTICLES
Placon Announces New Costa Rica Warehouse and Distribution Facility
Jun 02 2025 , Julie A. Vetalice
On a Mission to Create Equity in Worldwide Orthopedic Care
May 28 2025 , BONEZONE Editors
Himed and I&H Mark 15 Years of Strategic Sales Partnership
May 22 2025 , Julie A. Vetalice